Extrastriatal dopamine in symptomatic and asymptomatic rhesus monkeys treated with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)
Identifieur interne : 002739 ( Main/Exploration ); précédent : 002738; suivant : 002740Extrastriatal dopamine in symptomatic and asymptomatic rhesus monkeys treated with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)
Auteurs : Christian Pifl [Autriche] ; Oswald Bertel [Autriche] ; Günther Schingnitz [Allemagne] ; Oleh Hornykiewicz [Autriche]Source :
- Neurochemistry International [ 0197-0186 ] ; 1990.
Abstract
We analyzed in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated rhesus monkeys, with and without parkinsonian symptoms, the regional changes in dopamine (DA), 3,4-dihydroxyphenylacetic acid (DOPAC), homovanillic acid (HVA) and tyrosine hydroxylase activity (TH). Symptomatic monkeys had wide-spread DA loss in subcortical and cortical regions. However, the magnitude of this MPTP-induced DA reduction was markedly smaller than the DA loss in the caudate nucleus and putamen, where only less than 1% DA remained. No comparable loss of DA was found in the subcortical extrastriatal regions of asymptomatic MPTP monkeys, despite more than 90% DA loss in the striatal nuclei. The most pronounced difference in DA levels between the symptomatic and the asymptomatic group was observed in nucleus accumbens, nucleus of the stria terminalis, ventral tegmental area, globus pallidus and the cingulate gyrus. Levels of DOPAC and TH activity paralleled the behavior of DA. In contrast, the concentration of HVA was reduced in many brain regions of both symptomatic and asymptomatic monkeys. These effects of MPTP on extrastriatal DA levels in the rhesus monkey are compared with DA and HVA changes in the brain of patients with Parkinson's disease, and their possible contributory role for the production, by MPTP, of a permanent parkinsonian condition is discussed.
Url:
DOI: 10.1016/0197-0186(90)90148-M
Affiliations:
Links toward previous steps (curation, corpus...)
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title>Extrastriatal dopamine in symptomatic and asymptomatic rhesus monkeys treated with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)</title><author><name sortKey="Pifl, Christian" sort="Pifl, Christian" uniqKey="Pifl C" first="Christian" last="Pifl">Christian Pifl</name></author><author><name sortKey="Bertel, Oswald" sort="Bertel, Oswald" uniqKey="Bertel O" first="Oswald" last="Bertel">Oswald Bertel</name></author><author><name sortKey="Schingnitz, Gunther" sort="Schingnitz, Gunther" uniqKey="Schingnitz G" first="Günther" last="Schingnitz">Günther Schingnitz</name></author><author><name sortKey="Hornykiewicz, Oleh" sort="Hornykiewicz, Oleh" uniqKey="Hornykiewicz O" first="Oleh" last="Hornykiewicz">Oleh Hornykiewicz</name></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:6039C1DD4B333C12FA9B848F335A6AA7CAFF4EA4</idno><date when="1990" year="1990">1990</date><idno type="doi">10.1016/0197-0186(90)90148-M</idno><idno type="url">https://api.istex.fr/document/6039C1DD4B333C12FA9B848F335A6AA7CAFF4EA4/fulltext/pdf</idno><idno type="wicri:Area/Main/Corpus">002E49</idno><idno type="wicri:Area/Main/Curation">002A66</idno><idno type="wicri:Area/Main/Exploration">002739</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a">Extrastriatal dopamine in symptomatic and asymptomatic rhesus monkeys treated with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)</title><author><name sortKey="Pifl, Christian" sort="Pifl, Christian" uniqKey="Pifl C" first="Christian" last="Pifl">Christian Pifl</name><affiliation wicri:level="1"><country xml:lang="fr">Autriche</country><wicri:regionArea>Institute of Biochemical Pharmacology, University of Vienna, Borschkegasse 8A, A-1090 Vienna</wicri:regionArea><wicri:noRegion>A-1090 Vienna</wicri:noRegion></affiliation></author><author><name sortKey="Bertel, Oswald" sort="Bertel, Oswald" uniqKey="Bertel O" first="Oswald" last="Bertel">Oswald Bertel</name><affiliation wicri:level="1"><country xml:lang="fr">Autriche</country><wicri:regionArea>Institute of Biochemical Pharmacology, University of Vienna, Borschkegasse 8A, A-1090 Vienna</wicri:regionArea><wicri:noRegion>A-1090 Vienna</wicri:noRegion></affiliation></author><author><name sortKey="Schingnitz, Gunther" sort="Schingnitz, Gunther" uniqKey="Schingnitz G" first="Günther" last="Schingnitz">Günther Schingnitz</name><affiliation wicri:level="1"><country xml:lang="fr" wicri:curation="lc">Allemagne</country><wicri:regionArea>Boehringer Ingelheim KG, Department of Pharmacology, Ingelheim</wicri:regionArea><wicri:noRegion>Ingelheim</wicri:noRegion><wicri:noRegion>Ingelheim</wicri:noRegion></affiliation></author><author><name sortKey="Hornykiewicz, Oleh" sort="Hornykiewicz, Oleh" uniqKey="Hornykiewicz O" first="Oleh" last="Hornykiewicz">Oleh Hornykiewicz</name><affiliation wicri:level="1"><country xml:lang="fr">Autriche</country><wicri:regionArea>Institute of Biochemical Pharmacology, University of Vienna, Borschkegasse 8A, A-1090 Vienna</wicri:regionArea><wicri:noRegion>A-1090 Vienna</wicri:noRegion></affiliation></author></analytic><monogr></monogr><series><title level="j">Neurochemistry International</title><title level="j" type="abbrev">NCI</title><idno type="ISSN">0197-0186</idno><imprint><publisher>ELSEVIER</publisher><date type="published" when="1990">1990</date><biblScope unit="volume">17</biblScope><biblScope unit="issue">2</biblScope><biblScope unit="page" from="263">263</biblScope><biblScope unit="page" to="270">270</biblScope></imprint><idno type="ISSN">0197-0186</idno></series><idno type="istex">6039C1DD4B333C12FA9B848F335A6AA7CAFF4EA4</idno><idno type="DOI">10.1016/0197-0186(90)90148-M</idno><idno type="PII">0197-0186(90)90148-M</idno></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0197-0186</idno></seriesStmt></fileDesc><profileDesc><textClass></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">We analyzed in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated rhesus monkeys, with and without parkinsonian symptoms, the regional changes in dopamine (DA), 3,4-dihydroxyphenylacetic acid (DOPAC), homovanillic acid (HVA) and tyrosine hydroxylase activity (TH). Symptomatic monkeys had wide-spread DA loss in subcortical and cortical regions. However, the magnitude of this MPTP-induced DA reduction was markedly smaller than the DA loss in the caudate nucleus and putamen, where only less than 1% DA remained. No comparable loss of DA was found in the subcortical extrastriatal regions of asymptomatic MPTP monkeys, despite more than 90% DA loss in the striatal nuclei. The most pronounced difference in DA levels between the symptomatic and the asymptomatic group was observed in nucleus accumbens, nucleus of the stria terminalis, ventral tegmental area, globus pallidus and the cingulate gyrus. Levels of DOPAC and TH activity paralleled the behavior of DA. In contrast, the concentration of HVA was reduced in many brain regions of both symptomatic and asymptomatic monkeys. These effects of MPTP on extrastriatal DA levels in the rhesus monkey are compared with DA and HVA changes in the brain of patients with Parkinson's disease, and their possible contributory role for the production, by MPTP, of a permanent parkinsonian condition is discussed.</div></front></TEI><affiliations><list><country><li>Allemagne</li><li>Autriche</li></country></list><tree><country name="Autriche"><noRegion><name sortKey="Pifl, Christian" sort="Pifl, Christian" uniqKey="Pifl C" first="Christian" last="Pifl">Christian Pifl</name></noRegion><name sortKey="Bertel, Oswald" sort="Bertel, Oswald" uniqKey="Bertel O" first="Oswald" last="Bertel">Oswald Bertel</name><name sortKey="Hornykiewicz, Oleh" sort="Hornykiewicz, Oleh" uniqKey="Hornykiewicz O" first="Oleh" last="Hornykiewicz">Oleh Hornykiewicz</name></country><country name="Allemagne"><noRegion><name sortKey="Schingnitz, Gunther" sort="Schingnitz, Gunther" uniqKey="Schingnitz G" first="Günther" last="Schingnitz">Günther Schingnitz</name></noRegion></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002739 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 002739 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= ParkinsonV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= ISTEX:6039C1DD4B333C12FA9B848F335A6AA7CAFF4EA4
|texte= Extrastriatal dopamine in symptomatic and asymptomatic rhesus monkeys treated with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)
}}
| This area was generated with Dilib version V0.6.23. |  |